68483-62-5 Usage
General Description
1-Ethynyl-4,4-dimethylcyclohexanol is a chemical compound with the molecular formula C10H16O. It is an alcohol derivative that contains a cyclohexane ring with a triple bond attached to one of its carbon atoms. The presence of the ethynyl group in the molecule gives it unique properties and reactivity. 1-ethynyl-4,4-dimethylcyclohexanol is commonly used in organic synthesis as a building block for the preparation of various other organic compounds. It can also be used as a reagent in chemical reactions to introduce the ethynyl group into different molecules. The 4,4-dimethylcyclohexanol moiety in the compound contributes to its overall structure and physical properties. Overall, 1-Ethynyl-4,4-dimethylcyclohexanol is an important and versatile chemical compound with various applications in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 68483-62-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,4,8 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 68483-62:
(7*6)+(6*8)+(5*4)+(4*8)+(3*3)+(2*6)+(1*2)=165
165 % 10 = 5
So 68483-62-5 is a valid CAS Registry Number.
68483-62-5Relevant articles and documents
Halogen-Substituted Allenyl Ketones through Ring Opening of Nonstrained Cycloalkanols
Wu, Penglin,Ma, Shengming
supporting information, p. 2533 - 2537 (2021/04/13)
An efficient synthesis of halogen-substituted allenyl ketones via Ag-catalyzed oxidative ring opening of allenyl cyclic alcohols under mild reaction conditions has been achieved. The reaction features a wide substrate scope and excellent regioselectivity. The synthetic potential of the products has been demonstrated by their conversion to stereodefined alkenes and heterocyclic compounds.
GEM-DISUBSTITUTED AND SPIROCYCLIC AMINO PYRIDINES/PYRIMIDINES AS CELL CYCLE INHIBITORS
-
Page/Page column 68, (2009/11/29)
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are gem-disubstituted or spirocyclic pyridine, pyrimidine and triazine derivatives.